Vaughan Nelson Investment Management L.P. decreased its holdings in Fabrinet (NYSE:FN – Free Report) by 64.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,009 shares of the technology company’s stock after selling 35,095 shares during the quarter. Vaughan Nelson Investment Management L.P. owned approximately 0.05% of Fabrinet worth $8,654,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. Wasatch Advisors LP boosted its position in shares of Fabrinet by 45.1% in the second quarter. Wasatch Advisors LP now owns 1,779,665 shares of the technology company’s stock worth $524,432,000 after acquiring an additional 553,196 shares during the last quarter. Norges Bank acquired a new position in shares of Fabrinet in the 2nd quarter valued at $124,046,000. Invesco Ltd. boosted its holdings in shares of Fabrinet by 446.6% in the 2nd quarter. Invesco Ltd. now owns 511,553 shares of the technology company’s stock valued at $150,744,000 after purchasing an additional 417,959 shares during the last quarter. Alliancebernstein L.P. grew its stake in shares of Fabrinet by 226.1% during the 3rd quarter. Alliancebernstein L.P. now owns 499,177 shares of the technology company’s stock valued at $182,010,000 after buying an additional 346,113 shares during the period. Finally, Holocene Advisors LP purchased a new stake in shares of Fabrinet during the 3rd quarter valued at $124,847,000. Institutional investors and hedge funds own 97.38% of the company’s stock.
Analysts Set New Price Targets
FN has been the topic of several research reports. Wolfe Research raised Fabrinet from a “peer perform” rating to an “outperform” rating and set a $540.00 target price on the stock in a research report on Wednesday, February 4th. Weiss Ratings upgraded Fabrinet from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Tuesday, March 24th. Barclays raised their price objective on Fabrinet from $537.00 to $548.00 and gave the stock an “overweight” rating in a report on Tuesday, February 3rd. Needham & Company LLC reiterated a “buy” rating and set a $540.00 target price on shares of Fabrinet in a report on Tuesday, February 3rd. Finally, Rosenblatt Securities reissued a “buy” rating and set a $550.00 target price on shares of Fabrinet in a research report on Tuesday, February 3rd. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $541.25.
Fabrinet Trading Up 6.1%
Shares of NYSE FN opened at $521.80 on Wednesday. The stock has a fifty day moving average price of $516.48 and a 200 day moving average price of $462.27. Fabrinet has a 12-month low of $148.55 and a 12-month high of $632.99. The company has a market cap of $18.69 billion, a P/E ratio of 49.98 and a beta of 1.01.
Fabrinet (NYSE:FN – Get Free Report) last issued its quarterly earnings data on Monday, February 2nd. The technology company reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.26 by $0.10. The company had revenue of $1.13 billion for the quarter, compared to analysts’ expectations of $1.08 billion. Fabrinet had a return on equity of 18.69% and a net margin of 9.69%.The firm’s quarterly revenue was up 35.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.61 earnings per share. Fabrinet has set its Q3 2026 guidance at 3.450-3.600 EPS. On average, sell-side analysts forecast that Fabrinet will post 9.4 EPS for the current fiscal year.
Fabrinet Profile
Fabrinet is a global provider of advanced optical packaging and precision optical, electro‐mechanical and electronic manufacturing services (CEM). The company specializes in complex manufacturing processes for original equipment manufacturers (OEMs) in communications, data center, industrial, instrumentation and medical markets. Key capabilities include high‐precision fiber alignment, micro‐assembly, testing and diagnostics, and integration of electro‐optic subassemblies.
Incorporated in 2000, Fabrinet operates under a corporate structure headquartered in Singapore with additional regional offices and design centers in the Americas, Europe and Asia.
Recommended Stories
Want to see what other hedge funds are holding FN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fabrinet (NYSE:FN – Free Report).
Receive News & Ratings for Fabrinet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fabrinet and related companies with MarketBeat.com's FREE daily email newsletter.
